Cover Image
Market Research Report

Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023

Published by MarketsandMarkets Product code 620825
Published Content info 116 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023
Published: March 28, 2018 Content info: 116 Pages
Description

"The global cell dissociation market is projected to grow at a CAGR of 12.8% during the forecast period"

The cell dissociation market is expected to reach USD 440.5 million by 2023 from USD 241.2 million in 2018, at a CAGR of 12.8%. Factors driving the growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing lucrative opportunities for the players operating in the cell dissociation market.

"The non-enzymatic products segment is anticipated to grow at the fastest rate in the next five years"

Based on product, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories market. Among all, the non-enzymatic product segment is estimated to grow at the highest CAGR during the forecast period. This can be primarily attributed to advantages such as ready to use and non-toxic in nature.

"Tissue dissociation type segment is expected to dominate the cell dissociation market during the forecast period"

On the basis of type, the market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzymatic products and instruments & accessories in the pharmaceutical & biotechnology companies is the major driving factor for this segment.

"Asia Pacific is estimated to grow at the highest CAGR during the study period"

Geographically, the cell dissociation market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to infrastructural developments in the life sciences industry, rising government investments for chronic disease research, and presence of emerging economies such as China and India.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1-35%, Tier 2-22% and Tier 3- 43%
  • By Designation: C level-15%, Director level-32%, Others-53%
  • By Region: North America-34%, Europe-25%, Asia Pacific-23%, Rest of the World-18%

The key players in the cell dissociation market include: Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).

Research Coverage:

The report analyses the cell dissociation market by product, tissue, type, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the cell dissociation market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell dissociation market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the cell dissociation market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell dissociation products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell dissociation market
Table of Contents
Product Code: BT 6129

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL DISSOCIATION MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT & COUNTRY
  • 4.3. CELL DISSOCIATION MARKET, BY REGION
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE CELL DISSOCIATION MARKET (MAJOR COUNTRIES)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing R&D activities in biopharmaceutical companies
      • 5.2.1.2. Favorable funding scenario for cancer research
    • 5.2.2. OPPORTUNITIES
      • 5.2.2.1. Growth opportunities in emerging markets
    • 5.2.3. TRENDS
      • 5.2.3.1. Emergence of advanced tissue dissociation enzyme products
      • 5.2.3.2. Acceptance of enzyme-free dissociation products over enzymatic dissociation products

6. CELL DISSOCIATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ENZYMATIC DISSOCIATION PRODUCTS
    • 6.2.1. COLLAGENASE
    • 6.2.2. TRYPSIN
    • 6.2.3. PAPAIN
    • 6.2.4. ELASTASE
    • 6.2.5. DNASE
    • 6.2.6. HYALURONIDASE
    • 6.2.7. OTHER TISSUE DISSOCIATION ENZYMES
  • 6.3. NON-ENZYMATIC DISSOCIATION PRODUCTS
  • 6.4. INSTRUMENTS & ACCESSORIES

7. CELL DISSOCIATION MARKET, BY TISSUE

  • 7.1. INTRODUCTION
  • 7.2. CONNECTIVE TISSUE
  • 7.3. EPITHELIAL TISSUE
  • 7.4. OTHER TISSUES

8. CELL DISSOCIATION MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. TISSUE DISSOCIATION
  • 8.3. CELL DETACHMENT

9. CELL DISSOCIATION MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3. RESEARCH & ACADEMIC INSTITUTES
  • 9.4. OTHER END USERS

10. CELL DISSOCIATION MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET RANKING ANALYSIS
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. EXPANSIONS
    • 11.3.2. ACQUISITIONS
    • 11.3.3. AGREEMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. BD
  • 12.2. THERMO FISHER SCIENTIFIC
  • 12.3. F. HOFFMANN-LA ROCHE LTD.
  • 12.4. GE HEALTHCARE
  • 12.5. MERCK KGAA
  • 12.6. ATCC
  • 12.7. HIMEDIA LABORATORIES
  • 12.8. PAN-BIOTECH
  • 12.9. MILTENYI BIOTEC
  • 12.10. STEMCELL TECHNOLOGIES

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: R&D EXPENDITURE OF MAJOR BIOPHARMACEUTICAL COMPANIES, 2015 VS. 2016
  • TABLE 2: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 3: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 4: COLLAGENASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: NORTH AMERICA: COLLAGENASE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: TRYPSIN MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: NORTH AMERICA: TRYPSIN MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: PAPAIN MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: NORTH AMERICA: PAPAIN MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: ELASTASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: NORTH AMERICA: ELASTASE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: DNASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: DNASE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: HYALURONIDASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: NORTH AMERICA: HYALURONIDASE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: OTHER TISSUE DISSOCIATION ENZYMES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: NORTH AMERICA: OTHER TISSUE DISSOCIATION ENZYMES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: NORTH AMERICA: NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: NORTH AMERICA: CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: CELL DISSOCIATION MARKET, BY TISSUE, 2016-2023 (USD MILLION)
  • TABLE 23: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: CELL DISSOCIATION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 27: TISSUE DISSOCIATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: CELL DETACHMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 30: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: ASIA PACIFIC: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: CELL DISSOCIATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CELL DISSOCIATION MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 42: NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 44: US: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 45: US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: US: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 48: CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: CANADA: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 50: EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 51: EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 52: EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 53: ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 58: JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 61: CHINA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: CHINA: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 64: INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: INDIA: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 66: ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 67: ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: ROW: CELL DISSOCIATION MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 70: ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: ROW: CELL DISSOCIATION MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 72: TOP 5 COMPANIES IN THE CELL DISSOCIATION MARKET
  • TABLE 73: EXPANSIONS, 2014-2017
  • TABLE 74: ACQUISITIONS, 2014-2017
  • TABLE 75: AGREEMENTS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL DISSOCIATION MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: CELL DISSOCIATION MARKET, BY TISSUE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: CELL DISSOCIATION MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: CELL DISSOCIATION MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: CELL DISSOCIATION MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: INCREASING R&D INVESTMENTS BY PHARMACEUTICAL COMPANIES AND RISING FUNDING FOR CANCER RESEARCH TO DRIVE MARKET GROWTH
  • FIGURE 12: ENZYMATIC DISSOCIATION PRODUCTS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 13: NORTH AMERICA ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 14: INDIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: CELL DISSOCIATION MARKET: DRIVERS, OPPORTUNITIES, AND TRENDS
  • FIGURE 16: ENZYMATIC DISSOCIATION PRODUCTS TO DOMINATE THE CELL DISSOCIATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: CONNECTIVE TISSUE SEGMENT WILL CONTINUE TO DOMINATE THE CELL DISSOCIATION MARKET IN 2023
  • FIGURE 18: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL DISSOCIATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: NORTH AMERICA TO DOMINATE THE GLOBAL CELL DISSOCIATION MARKET IN 2018
  • FIGURE 20: NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT
  • FIGURE 22: EXPANSION - KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2014 AND 2017
  • FIGURE 23: BD: COMPANY SNAPSHOT (2017)
  • FIGURE 24: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 25: F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2017)
  • FIGURE 26: GE HEALTHCARE: COMPANY SNAPSHOT (2017)
  • FIGURE 27: MERCK KGAA: COMPANY SNAPSHOT (2016)
Back to Top